看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯，血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
9 a+ z( m0 [7 W: T# u, B7 n5 g* [: O$ a5 Z' D1 K
7 l* F4 N$ U$ `2 a' k# g- H8 d- `Currently available feasibility data for possible combination strategies.
7 E" ~( Y1 l; g& I& Q————————————————————————————————
7 ^7 u; {; c1 W, ^: V g8 Y/ yCombination Feasibility according to preliminary data
& ^, {7 x+ L2 R+ v2 Q N——————————————————————————————————
7 } Q8 T n# N7 y @# \! w, o4 ZBevacizumab + sorafenib Yes, reduced dose
; P% A, `! Z m9 F, `% MBevacizumab + sunitinib† No : C$ H9 \1 E; z
Bevacizumab + temsirolimus Yes M w% O2 ]; S; y9 J
Bevacizumab + everolimus Yes
0 f/ R3 c, Q6 {, ^1 YSorafenib + sunitinib ?
& L$ s- [' ~" d9 b+ }1 }Sorafenib + temsirolimus Yes, reduced dose , |' }$ D9 e" f' E- B
Sorafenib + everolimus Yes, reduced dose
4 ~" l1 G! f" wSunitinib + temsirolimus† No
: V7 g6 w9 h- }4 z! fSunitinib + everolimus ?
1 H0 f! T5 P6 `! W# s# s1 Q$ c5 aTemsirolimus + everolimus ? 2 u# w) ~% `1 n1 r
————————————————————; l6 \' }# E$ L4 g$ B
†Led to US FDA warning./ |4 J, X. G$ p) |1 h
?: As yet unattempted combination.
2 t4 g) o% E+ A9 `2 D F$ i3 c |
显身卡
6 A8 b" ?" o9 S$ c( a
